reboxetine has been researched along with dextrorphan in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (dextrorphan) | Trials (dextrorphan) | Recent Studies (post-2010) (dextrorphan) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 456 | 45 | 55 |
| Protein | Taxonomy | reboxetine (IC50) | dextrorphan (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 6 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.773 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 1.3 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.246 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avenoso, A; Facciolà, G; Scordo, MG; Spina, E | 1 |
1 trial(s) available for reboxetine and dextrorphan
| Article | Year |
|---|---|
No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers.
Topics: Adult; Antidepressive Agents; Cross-Over Studies; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Drug Interactions; Enzyme Inhibitors; Female; Humans; Isoenzymes; Male; Morpholines; Paroxetine; Phenotype; Reboxetine; Time Factors | 1999 |